Toxicity and drug interactions associated with herbal products: Ephedra and St. John's Wort

Christopher P. Holstege, Kara Mitchell, Kevin Barlotta, R Furbee

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Health care providers are being increasingly confronted with the use of herbal medications by their patients. It is imperative that patients be questioned regarding herbal preparation use and that health care providers become familiar with these agents. Research into the active components and mechanisms of action of various herbals is ongoing [350]. Long-range studies need to be performed to follow patients for efficacy or toxicity in chronic use [351,352]. Adverse reactions to herbal remedies should be reported to the FDA MedWatch at http://www.fda.gov/medwatch. As with any therapeutic agent, risk of use must always be weighed against potential benefits.

Original languageEnglish
Pages (from-to)1225-1257
Number of pages33
JournalMedical Clinics of North America
Volume89
Issue number6
DOIs
StatePublished - Nov 2005

Fingerprint

Ephedra
Hypericum
Drug Interactions
Health Personnel
Plant Preparations
Research
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Toxicity and drug interactions associated with herbal products : Ephedra and St. John's Wort. / Holstege, Christopher P.; Mitchell, Kara; Barlotta, Kevin; Furbee, R.

In: Medical Clinics of North America, Vol. 89, No. 6, 11.2005, p. 1225-1257.

Research output: Contribution to journalArticle

Holstege, Christopher P. ; Mitchell, Kara ; Barlotta, Kevin ; Furbee, R. / Toxicity and drug interactions associated with herbal products : Ephedra and St. John's Wort. In: Medical Clinics of North America. 2005 ; Vol. 89, No. 6. pp. 1225-1257.
@article{dceafb0f8c784e498a1556d44b492ec7,
title = "Toxicity and drug interactions associated with herbal products: Ephedra and St. John's Wort",
abstract = "Health care providers are being increasingly confronted with the use of herbal medications by their patients. It is imperative that patients be questioned regarding herbal preparation use and that health care providers become familiar with these agents. Research into the active components and mechanisms of action of various herbals is ongoing [350]. Long-range studies need to be performed to follow patients for efficacy or toxicity in chronic use [351,352]. Adverse reactions to herbal remedies should be reported to the FDA MedWatch at http://www.fda.gov/medwatch. As with any therapeutic agent, risk of use must always be weighed against potential benefits.",
author = "Holstege, {Christopher P.} and Kara Mitchell and Kevin Barlotta and R Furbee",
year = "2005",
month = "11",
doi = "10.1016/j.mcna.2005.08.002",
language = "English",
volume = "89",
pages = "1225--1257",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Toxicity and drug interactions associated with herbal products

T2 - Ephedra and St. John's Wort

AU - Holstege, Christopher P.

AU - Mitchell, Kara

AU - Barlotta, Kevin

AU - Furbee, R

PY - 2005/11

Y1 - 2005/11

N2 - Health care providers are being increasingly confronted with the use of herbal medications by their patients. It is imperative that patients be questioned regarding herbal preparation use and that health care providers become familiar with these agents. Research into the active components and mechanisms of action of various herbals is ongoing [350]. Long-range studies need to be performed to follow patients for efficacy or toxicity in chronic use [351,352]. Adverse reactions to herbal remedies should be reported to the FDA MedWatch at http://www.fda.gov/medwatch. As with any therapeutic agent, risk of use must always be weighed against potential benefits.

AB - Health care providers are being increasingly confronted with the use of herbal medications by their patients. It is imperative that patients be questioned regarding herbal preparation use and that health care providers become familiar with these agents. Research into the active components and mechanisms of action of various herbals is ongoing [350]. Long-range studies need to be performed to follow patients for efficacy or toxicity in chronic use [351,352]. Adverse reactions to herbal remedies should be reported to the FDA MedWatch at http://www.fda.gov/medwatch. As with any therapeutic agent, risk of use must always be weighed against potential benefits.

UR - http://www.scopus.com/inward/record.url?scp=26844445307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26844445307&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2005.08.002

DO - 10.1016/j.mcna.2005.08.002

M3 - Article

C2 - 16227061

AN - SCOPUS:26844445307

VL - 89

SP - 1225

EP - 1257

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 6

ER -